Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

Clinical trial NCT05407389 · SUSPENDED

Trial details

NCT number: NCT05407389
Sponsor: Kibow Pharma
Status: SUSPENDED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease stage4

Start date: 2022-04-21
Primary completion: 2025-12-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.